PMD68 Cost-Effectiveness of Sacral Neuromodulation in the Treatment of Idiopathic Wet Refractory Overactive Bladder in Italy

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.917
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Mp77-14 Sacral Neuromodulation for Refractory Overactive Bladder After Prior Intravesical Onabotulinumtoxina Treatment.

Journal of Urology
Urology
2016English

Sacral Neuromodulation for Treatment of Overactive Bladder: A Review

Revista de Medicina
2018English

The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA Trial

Contemporary Clinical Trials
MedicinePharmacology
2014English

Neuromodulation for Refractory Overactive Bladder in Men

Trends in Urology & Men's Health
2018English

A Comparative Study Between Sacral Neuromodulation and Intravesical Botulinum Toxin Injection for Patients With Refractory Overactive Bladder

Arab Journal of Urology
Urology
2020English

The Second-Line Management of Idiopathic Overactive Bladder: What Is the Place of Sacral Neuromodulation and Botulinum Toxin-A in Contemporary Practice?

BJU International
Urology
2009English

Pelvic Electrical Neuromodulation for the Treatment of Overactive Bladder Symptoms

Advances in Urology
GynecologyUrologyObstetrics
2011English

Two-Year Safety and Efficacy Outcomes for the Treatment of Overactive Bladder Using a Long-Lived Rechargeable Sacral Neuromodulation System

Neurourology and Urodynamics
NeurologyUrology
2020English

Sacral Neuromodulation in Children and Adolescents With Chronic Constipation Refractory to Conservative Treatment

International Journal of Colorectal Disease
Gastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy